1. Desmopressin

   • Domenic A. Sica
   • Todd W.B. Gehr

   Editorial 20 November 2012 Pages: 553 - 556

2. Use of the Dose, Time, Susceptibility (DoTS) Classification Scheme for Adverse Drug Reactions in Pharmacovigilance Planning

   • Torbjörn Callréus

   Current Opinion 20 November 2012 Pages: 557 - 566

   

3. Heart Failure Induced by Non-Cardiac Drugs

   • Lars Slørdal
   • Olav Spigset

   Review Article 20 November 2012 Pages: 567 - 586

   

4. Second-Generation Antipsychotics

   • Wolfgang Aichhorn
   • Alexandra B. Whitworth
   • Josef Marksteiner

   Review Article 20 November 2012 Pages: 587 - 598

   

5. Clinical Safety of Inhaled Corticosteroids for Asthma in Children

   • Søren Pedersen

   Review Article 20 November 2012 Pages: 599 - 612

   

6. Increase in Nonfatal Digestive Perforations and Haemorrhages Following Introduction of Selective NSAIDs

   • Louise Barnard
   • Dominic Lavoie
   • Nancy Lajeunesse

   Original Research Article 20 November 2012 Pages: 613 - 620

   

7. Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

   • Stephen P. Motsko
   • Karen L. Rascati
   • Jason Worchel

   Original Research Article 20 November 2012 Pages: 621 - 632

   

8. Safety of Inhalation of a 50% Nitrous Oxide/Oxygen Premix

   • Peter Onody
   • Pascal Gil
   • Martine Hennequin

   Original Research Article 20 November 2012 Pages: 633 - 640

   

9. A Survey of the Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting by Clinicians in Eastern India

   • Suparna Chatterjee
   • Nazmun Lyle
   • Souvik Ghosh

   Correspondence 20 November 2012 Pages: 641 - 642